UK partnership aims to revolutionise imaging for drug development
04 May 2021
Nine-partner project including Zepler Institute will develop imaging technologies âat unprecedented resolution and speedâ.
The collaboration is one of nine Prosperity Partnerships announced by the UK Government, to be funded by a total £75 million ($104 million) investment from business, academia and UK Research and Innovation s (UKRI) Engineering and Physical Sciences Research Council (EPSRC).
Professor Sumeet Mahajan, Professor in Molecular Biophotonics and Imaging at ZIPN, commented, âThis partnership will bring together technology developers and end-users to create transformative opportunities in quantitative imaging of 3D biological samples.
âNovel volume imaging technologies at unprecedented resolution and speed, augmented by machine learning, will bring about a step change in the pre-clinical testing of drug candidates for the pharmaceutical industry and for evaluating t
Share
A new partnership between the University of Southampton, M Squared and global pharmaceutical company AstraZeneca will look at how the process of drug and medicine discovery can be sped up and its efficiency improved.
The collaboration is one of nine Prosperity Partnerships announced by Science Minister Amanda Solloway to be funded by a total £75 million investment from business, academia and UK Research and Innovation’s (UKRI) Engineering and Physical Sciences Research Council (EPSRC).
The Partnerships build on existing UK strengths in academia and industry to develop new technologies, processes, and skills that will deliver economic growth and create jobs in areas across the UK.